What does CUSIP 413197104 represent in this 13F holders report?

CUSIP 413197104 is the security identifier for HRMY - Harmony Biosciences Holdings, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held HRMY - Harmony Biosciences Holdings, Inc. - Common Stock in Q2 2022?

173 institutional investors reported HRMY - Harmony Biosciences Holdings, Inc. - Common Stock for Q2 2022. Use the holders table for investor-level position and value details.

Harmony Biosciences Holdings, Inc. - Common Stock (HRMY)

CUSIP: 413197104

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock
Shares outstanding: 57,644,670
Total 13F shares: 47,874,920
Share change: +2,009,982
Total reported value: $2,335,182,718
Put/Call ratio: 9.5%
Price per share: $48.77
Number of holders: 173
Value change: +$99,684,851
Number of buys: 95
Number of sells: 80

Quarterly Holders Quick Answers

What is CUSIP 413197104?
CUSIP 413197104 identifies HRMY - Harmony Biosciences Holdings, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 413197104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of HRMY - Harmony Biosciences Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Valor Management LLC	13F	Company	19%	11,218,033	$545,757,000	—	31 Mar 2022	13F
FMR LLC	13F	Company	8.5%	4,897,182	$238,249,000	—	31 Mar 2022	13F
Vivo Capital, LLC	13F	Company	7.9%	4,570,148	$222,338,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	6.6%	3,832,919	$186,470,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	4.7%	2,702,513	$131,478,000	—	31 Mar 2022	13F
JANUS HENDERSON GROUP PLC	13F	Company	2.8%	1,604,909	$78,075,000	—	31 Mar 2022	13F
venBio Partners LLC	13F	Company	2.7%	1,544,484	$75,139,000	—	31 Mar 2022	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	2%	1,132,216	$55,082,000	—	31 Mar 2022	13F
Blackstone Inc.	13F	Company	1.8%	1,048,951	$51,031,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	1.4%	828,181	$40,291,000	—	31 Mar 2022	13F
Nan Fung Group Holdings Ltd	13F	Company	1.3%	768,708	$37,398,000	—	31 Mar 2022	13F
ASHFORD CAPITAL MANAGEMENT INC	13F	Company	1.1%	659,873	$32,103,000	—	31 Mar 2022	13F
Newlight Partners LP	13F	Company	1.1%	651,372	$31,689,000	—	31 Mar 2022	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.98%	566,308	$27,551,000	—	31 Mar 2022	13F
Polar Capital Holdings Plc	13F	Company	0.95%	550,000	$26,758,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.77%	441,614	$21,484,000	—	31 Mar 2022	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	0.36%	205,474	$20,533,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.7%	401,086	$19,762,000	—	31 Mar 2022	13F
MACQUARIE GROUP LTD	13F	Company	0.7%	405,368	$19,721,000	—	31 Mar 2022	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	0.68%	389,760	$18,962,000	—	31 Mar 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.6%	346,052	$16,837,000	—	31 Mar 2022	13F
Aisling Capital Management LP	13F	Company	0.59%	342,815	$16,678,000	—	31 Mar 2022	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	0.52%	300,000	$14,595,000	—	31 Mar 2022	13F
Hood River Capital Management LLC	13F	Company	0.52%	298,943	$14,544,000	—	31 Mar 2022	13F
Rhenman & Partners Asset Management AB	13F	Company	0.47%	268,244	$13,050,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.45%	260,391	$12,669,000	—	31 Mar 2022	13F
ROYCE & ASSOCIATES LP	13F	Company	0.44%	255,807	$12,445,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.4%	233,134	$11,342,000	—	31 Mar 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.4%	228,000	$11,092,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.38%	217,304	$10,572,000	—	31 Mar 2022	13F
ROTHSCHILD & CO ASSET MANAGEMENT US INC.	13F	Company	0.38%	216,737	$10,544,000	—	31 Mar 2022	13F
Invesco Ltd.	13F	Company	0.35%	202,308	$9,843,000	—	31 Mar 2022	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.34%	195,738	$9,523,000	—	31 Mar 2022	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.33%	192,973	$9,388,000	—	31 Mar 2022	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.3%	172,400	$8,387,000	—	31 Mar 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.29%	168,479	$8,197,000	—	31 Mar 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.29%	166,800	$8,115,000	—	31 Mar 2022	13F
FIRST TRUST ADVISORS LP	13F	Company	0.28%	162,400	$7,901,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.28%	161,568	$7,861,000	—	31 Mar 2022	13F
FIRST MANHATTAN CO. LLC.	13F	Company	0.27%	153,673	$7,476,000	—	31 Mar 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.25%	142,500	$6,933,000	—	31 Mar 2022	13F
MPM BioImpact LLC	13F	Company	0.24%	137,517	$6,690,000	—	31 Mar 2022	13F
Bellevue Group AG	13F	Company	0.22%	124,961	$6,079,000	—	31 Mar 2022	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	0.21%	123,682	$6,017,000	—	31 Mar 2022	13F
BAKER BROS. ADVISORS LP	13F	Company	0.21%	123,600	$6,013,000	—	31 Mar 2022	13F
Atle Fund Management AB	13F	Company	0.21%	120,000	$5,838,000	—	31 Mar 2022	13F
Man Group plc	13F	Company	0.2%	117,970	$5,740,000	—	31 Mar 2022	13F
Cubist Systematic Strategies, LLC	13F	Company	0.16%	94,787	$4,611,000	—	31 Mar 2022	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.16%	94,425	$4,594,000	—	31 Mar 2022	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.16%	90,267	$4,391,000	—	31 Mar 2022	13F

Institutional Holders of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) as of Q2 2022

As of 30 Jun 2022, Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) was held by 173 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 47,874,920 shares. The largest 10 holders included Valor Management LLC, FMR LLC, Vivo Capital, LLC, BlackRock Inc., VANGUARD GROUP INC, venBio Partners LLC, JANUS HENDERSON GROUP PLC, Blackstone Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., and STATE STREET CORP. This page lists 174 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

168

Q2 2022 holders

173

Holder diff

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.